SIRT2 and metabolic dysfunction-associated steatotic liver disease: Importantly, in our previous study we showed that SIRT2 counteracts insulin resistance in hepatocytes by mitigating oxidative stress and mitochondrial dysfunction [22], which are common pathogenic events in NAFLD.